Cyclopharm secured an interim agreement to supply the US Veterans Health Administration with the pharmaceutical and consumable components of Technegas, according to a Thursday filing with the Australian Securities Exchange.
The agreement grants 120 Veterans Affairs hospitals access to an agreed contract for the products, the filing said.
Additionally, the company received the first purchase order for Technegas from a Department of Defense hospital, according to the filing.
Shares rose 3% in morning trade.
Price (AUD): $1.52, Change: $+0.050, Percent Change: +3.40%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。